Greer Massey, PhD, is chief scientific officer at Molecular Designs. Previously, Massey led Research & Development at Assurance Scientific, where she directed efforts for their SARS-CoV-2 emergency use authorization for symptomatic and asymptomatic testing. She also helped establish their consulting services. Before that, Massey managed the Bioanalytical Department at Southern Research and developed multiplex assays and their lyophilization as senior products manager at BioGX, Inc. Massey received both her MS in biology and PhD in microbiology from the University of Alabama at Birmingham.
Articles by Greer Massey, PhD
|2 min read
FDA LDT Rule Reversal Signals Return to Innovation, Flexibility, and Established Regulation
The innovative capabilities of LDTs should endure as long as the field remains data-driven, standards-compliant, and committed to continuous quality improvementPage 1 of 1
